Price
Target price
€62.00
€62.00
-0.800%
-0.5
-0.800%
€66.53
18.04.24 / Frankfurt
WKN: A2N7B2 / Symbol: AXNX / Name: Axonics Modulation Technologies / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Axonics Modulation Technologies Inc Stock
Axonics Modulation Technologies Inc shows a slight decrease today, losing -€0.500 (-0.800%) compared to yesterday.
Axonics Modulation Technologies Inc is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
As a result the target price of 66 € shows a slightly positive potential of 6.45% compared to the current price of 62.0 € for Axonics Modulation Technologies Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Axonics Modulation Technologies Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Axonics Modulation Technologies Inc in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Axonics Modulation Technologies Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Axonics Modulation Technologies Inc | -0.800% | -0.800% | -0.800% | 21.569% | 8.772% | 26.016% | - |
| Orasure Tech | - | -8.785% | -21.920% | -18.667% | -34.497% | -40.313% | -41.543% |
| scPharmaceuticals | -4.310% | -14.530% | -20.792% | -55.801% | -30.435% | -26.606% | - |
| SI-BONE Inc | -0.700% | -2.083% | -3.425% | -22.951% | -25.789% | -49.643% | - |
Comments
Axonics, Inc. (NASDAQ: AXNX) had its price target raised by analysts at Truist Financial Co. from $65.00 to $73.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) had its price target lowered by analysts at Piper Sandler from $84.00 to $75.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) had its price target lowered by analysts at Needham & Company LLC from $76.00 to $63.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AXNX provided by MarketBeat
